PRF TECHNOLOGIES LTD
PRFXNASDAQTrading Snapshot
- Day Range
- $0.96 – $0.98
- 52-Week Range
- $0.85 – $7.95
- Volume
- $4.26B
- Avg Volume
- $5.04B
- Shares Outstanding
- 3.0M
- Next Earnings
- Nov 18, 2026
Fundamentals Snapshot
- Annual Revenue
- $17,000
- Last Q Revenue
- $7,000
- P/E Ratio
- —
- P/S Ratio
- —
- EPS (TTM)
- $-9.71
- Dividend Yield
- —
- Dilution (1yr)
- +1000.9%
Why Investors Own PRFX
- ✓High-growth profile — revenue up +53.9% YoY with expanding US Equity exposure.
- ✓Healthy economics — 52% gross margin and 8% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
PRF TECHNOLOGIES LTD
PRFX
StockOtter · stockotter.spaceAbout PRF TECHNOLOGIES LTD
PRF Technologies Ltd. operates as a specialized pharmaceutical company, currently in the clinical development stage, with a focus on pioneering treatments that deliver sustained post-surgical pain management. Central to its pipeline is PRF-110, a distinctive clear, viscous, oil-based solution. This innovative product is engineered for direct application into surgical incisions, aiming to provide targeted and prolonged alleviation of discomfort following operations. PRF-110 is presently undergoing assessment in two pivotal Phase 3 clinical trials, specifically for individuals recovering from bunionectomy and hernia repair procedures. The company, which was originally incorporated in 2007 under the name PainReform Ltd., maintains its headquarters in Tel Aviv, Israel.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Ratings
ⓘLatest News & Updates
PRF Technologies' GridFeed(TM) to Explore Strategic Growth Opportunity in AI Data Center Power Optimization
IEA projects global data center electricity consumption to roughly double to 950 TWh by 2030, with consumption from AI-focused data centers expected to triple Company believes GridFeed's existing AI optimization engine i
PainReform Ltd. (NASDAQ:PRFX) Sees Significant Decrease in Short Interest
PainReform Ltd. (NASDAQ: PRFX - Get Free Report) was the recipient of a large drop in short interest during the month of August. As of August 31st, there was short interest totaling 47,016 shares, a drop of 76.6% from th
PRF Technologies to Establish GridFeed™ as a Standalone Subsidiary to Pursue Strategic Alliances for Its AI-Driven Renewable Energy Trading Platform
New structure designed to enable direct strategic investment, partnerships, and commercial collaborations GridFeed built on validated AI technology and commercial engagements with leading renewable energy companies Platf
PRF Technologies Provides First Half 2026 Business Update Highlighting Significant Progress Across Healthcare and AI Energy Business
FDA cleared the IND for OcuRing™-K, enabling a U.S. multi-center Phase II trial in cataract surgery with patient enrollment expected in the second half of 2026
PRF Technologies Issues Letter to Shareholders Highlighting Strengthened Financial Position and Building Momentum Across Its Biotechnology and AI-Driven Energy Platforms
Interim CEO Efraim Cohen-Arazi Details $10 Million in New Capital, LayerBio's Preparations for the Planned Phase 2 Clinical Trial of OcuRing™-K, and DeepSolar's Advance Toward Commercial Launch Interim CEO Efraim Cohen-A
PRF Technologies to Showcase GridFeed™ at Energy Trading Week Europe 2026
TEL AVIV, Israel, July 21, 2026 (GLOBE NEWSWIRE) -- PRF Technologies Ltd. (Nasdaq: PRFX) (“PRF” or the “Company”) today announced that its DeepSolar business unit will participate in Energy Trading Week Europe 2026, taki